Skip to content
★ Sign in to follow
RM

Richard Mulligan

Board Director
Director
Biogen Inc.Bausch Health Companies Inc.Sana Biotechnology, Inc.Viskase Holdings, Inc.
Total declarations
39
Companies
4
▲ Purchases (0 ops.)
—
▼ Sales (13 ops.)
€9.7M

Latest filing published 20 May 2025 for Bausch Health Companies Inc..

Filing timeline

BuySale
Richard Mulligan

Insider track record

Disclosed buys
0
Disclosed sells
13
Signal history

Richard Mulligan: trading record in brief

Richard Mulligan, listed as board member, has filed trades across 4 companies (mainly through SEC (Form 4)), most often in Biogen Inc., Bausch Health Companies Inc. and Viskase Holdings, Inc. We count 39 filings; the first trade dates from 21 May 2009 and the latest from 16 May 2025.

The open-market record consists of 13 sales worth €9.7M, with no purchase. Other entries cover 23 share grants and 3 option exercises.

On 20 May 2025 came the latest disclosure, a share grant in Bausch Health Companies Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Richard Mulligan

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations38 total

25 of 38 declarations